Similar articles

• [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].

  Pigrau A, Martínez-Vázquez JM, Bacardí R, Ocanña I, Pahissa A. Pigrau A, et al. Med Clin (Barc). 1984 Dec 8;83(19):787-91. Med Clin (Barc). 1984. PMID: 6335542 Spanish. No abstract available.
• [Nephropathy in the prognosis of systemic lupus erythematosus].

  Zanetti NL, Fernández AE, Spresi FN, Marini A, Juárez Peñalva H, Capdevila A. Zanetti NL, et al. Medicina (B Aires). 1982;42(2):127-35. Medicina (B Aires). 1982. PMID: 6983021 Spanish. No abstract available.
• Membranous glomerulopathy in systemic lupus erythematosus.

  Gonzalez-Dettoni H, Tron F. Gonzalez-Dettoni H, et al. Adv Nephrol Necker Hosp. 1985;14:347-64. Adv Nephrol Necker Hosp. 1985. PMID: 3919538 Review. No abstract available.
• Acute deterioration in renal function in systemic lupus erythematosus.

  Yeung CK, Ng WL, Wong WS, Wong KL, Chan MK. Yeung CK, et al. Q J Med. 1985 Jul;56(219):393-402. Q J Med. 1985. PMID: 4095251
• Complement deposition in the kidney.

  Berger J. Berger J. Adv Nephrol Necker Hosp. 1974;4:37-48. Adv Nephrol Necker Hosp. 1974. PMID: 4219998 Review. No abstract available.